title: BCG in management of transitional cell carcinoma invasive to prostate.
abstract: Transitional cell carcinoma invading the prostate is a difficult problem to manage. Transurethral resection of the bladder neck followed by intravesical bacillus Calmette-Guerin (BCG) is one suggested option.
authors.affiliation: Division of Urology, Cook County Hospital, Illinois.
authors.forename: P
authors.initials: P
authors.lastname: Siami
authors.forename: S
authors.initials: S
authors.lastname: Chinn
authors.forename: M
authors.initials: M
authors.lastname: Clayton
authors.forename: V
authors.initials: V
authors.lastname: Ray
authors.forename: M
authors.initials: M
authors.lastname: Rubenstein
authors.forename: P
authors.initials: P
authors.lastname: Guinan
mesh_terms: D000368:Aged; D001500:BCG Vaccine / Q000627:therapeutic use*; D002278:Carcinoma in Situ / Q000473:pathology / Q000628:therapy*; D002295:Carcinoma, Transitional Cell / Q000473:pathology / Q000628:therapy*; D006801:Humans; D008297:Male; D009361:Neoplasm Invasiveness; D009367:Neoplasm Staging; D009378:Neoplasms, Multiple Primary / Q000628:therapy*; D011471:Prostatic Neoplasms / Q000473:pathology / Q000628:therapy*; D001749:Urinary Bladder Neoplasms / Q000473:pathology / Q000628:therapy*
chemical_list: D001500:BCG Vaccine